Neurology

You are here

Trial Directory

Stroke, Critical Care & Neurohospitalist Program

Progesterone for the treatment of Traumatic Brain Injury (ProTECT III)

Status: Closed

Principal Investigator: Dianne M. Augelli, MD

Read More

TEACH - A Pilot Trial of Enoxaparin versus Aspirin in Patients with Cancer and Stroke

Status: Open for Enrollment

Principal Investigator: Babak Navi, MD

Additional Cornell Investigator: Hooman Kamel, MD

Read More

MISTIE III: A phase III, randomized, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage.

Status: Open for Enrollment

Principal Investigator: Dana Leifer, MD

Phone: 212-746-6538

Read More

SOURCE: Supraventricular Ectopy And Markers Of Cardiac Embolism

Status: Open for Enrollment

Principal Investigator: Hooman Kamel, MD

Additional Cornell Investigator: Babak Navi, MD

Read More

SWIFT PRIME: Solitaire™ FR With the Intention For Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke

Status: Open for Enrollment

Principal Investigator: Dana Leifer, MD

Phone: (212) 746-2454

Read More

Platelet-Oriented Inhibition in New TIA and minor ischemic stroke (POINT) Trial

Status: Open for Enrollment

Principal Investigator: Babak Navi, MD

Stroke Hyperglycemic Insulin Network Effort (SHINE)

Status: Open for Enrollment

Principal Investigator: Halinder Mangat, MD

Parkinson's Disease & Movement Disorders Institute

BioFIND: Fox Investigation for New Discovery of Parkinson's Disease Biomarkers

Status: Open for Enrollment

Principal Investigator: Claire Henchcliffe, MD, D.Phil

Phone: (212) 746-2474

Read More

Biogen Parkinson's Disease Biomarker Imaging Study

Status: Open for Enrollment

Principal Investigator: Claire Henchcliffe, MD, D.Phil

Phone: 212-746-2474

Additional Investigator: P. David Mozley

Read More

N-acetylcysteine for neuroprotection in Parkinson's disease

Status: Open for Enrollment

Principal Investigator: Claire Henchcliffe, MD, D.Phil

Phone: (212) 746-2474

Additional Investigator: Dikoma Shungu

Judith Jaffe Multiple Sclerosis Center

Ascertaining the influence of Gilenya® (FTY720) on the innate immune burden in multiple sclerosis - Healthy Volunteers Needed

Status: Open for Enrollment

Principal Investigator: Susan Gauthier, DO, MPH

Phone: (646) 962-5736

Read More

Remyelination and preservation of neuronal integrity with natalizumab treatment

Status: Closed

Principal Investigator: Susan Gauthier, DO, MPH

Ascertaining the impact of natalizumab (Tysabri®) on the true inflammatory burden in Multiple Sclerosis

Status: Closed

Principal Investigator: Susan Gauthier, DO, MPH

Measuring active microglia in progressive multiple sclerosis

Status: Open for Enrollment

Principal Investigator: Susan Gauthier, DO, MPH

Phone: (646) 962-5736

Read More

Examination of serum, cerebrospinal fluid (CSF) and stool for exposure to bacterial toxins that target myelin and the blood brain barrier in Multiple Sclerosis (MS)

Status: Open for Enrollment

Principal Investigator: Timothy Vartanian, MD, PhD

STRIVE-A Multicenter, Observational, Open-Label, Single-Arm Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients

Status: Open for Enrollment

Principal Investigator: Jai Perumal, MD

Weill Cornell Multiple Sclerosis Database

Status: Open for Enrollment

Principal Investigator: Susan Gauthier, DO, MPH

Peripheral Neuropathy Center

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

Status: Open for Enrollment

Principal Investigator: Norman Latov, MD, PhD

Phone: (646) 962-2149

Additional Cornell Investigator: Russell L. Chin, MD, Jennifer A. Langsdorf, MD

Read More

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

Status: Open for Enrollment

Principal Investigator: Norman Latov, MD, PhD

Phone: (646) 962-2149

Additional Cornell Investigator: Russell L. Chin, MD, Jennifer A. Langsdorf, MD

Read More

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

Status: Open for Enrollment

Principal Investigator: Norman Latov, MD, PhD

Phone: (646) 962-2149

Read More

Characteristics of Patients with Sensory Neuropathy Diagnosed with Abnormal Sweat Gland Nerve Density on Skin Biopsy

Status: Open for Enrollment

Principal Investigator: Russell L. Chin, MD

International Guillain-Barre Syndrome Outcome Study (IGOS): A prospective Inflammatory Neuropathy Consortium (INC) study on clinical and biological predictors of disease course and outcome in Guillain-Barre Syndrome (GBS)

Status: Open for Enrollment

Principal Investigator: Russell L. Chin, MD

Center for Sleep Medicine

Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea

Status: Open for Enrollment

Principal Investigator: Ana C. Krieger, MD, MPH

Weill Cornell Medicine Neurology 520 East 70th Street (at York Avenue) Starr Pavilion 607 New York, NY 10021 Phone: (212) 746-2596